| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 86 |
| 1 | AFLIBERCEPT | 61 |
| 2 | POVIDONE-IODINE | 33 |
| 3 | DEXAMETHASONE | 29 |
| 4 | BEVACIZUMAB-AWWB | 23 |
| 5 | DEXAMETHASONE 1.5 MG | 21 |
| 6 | VANCOMYCIN | 20 |
| 7 | VANCOMYCIN HYDROCHLORIDE | 20 |
| 8 | PREDNISONE | 17 |
| 9 | CEFTAZIDIME | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PHENYLEPHRINE AND KETOROLAC | 2 | 0.0244 |
| 1 | PROPARACAINE HYDROCHLORIDE | 9 | 0.0169 |
| 2 | TETRACAINE | 6 | 0.0152 |
| 3 | CYCLOPENTOLATE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0145 |
| 4 | AVACINCAPTAD PEGOL | 3 | 0.0085 |
| 5 | POVIDONE-IODINE | 33 | 0.0077 |
| 6 | PEGCETACOPLAN | 13 | 0.0068 |
| 7 | BEVACIZUMAB-AWWB | 23 | 0.0049 |
| 8 | BALANCED SALT SOLUTION | 6 | 0.0046 |
| 9 | DIFLUPREDNATE OPHTHALMIC | 4 | 0.0045 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cyclooxygenase Inhibitor [EPC] | 2 | 0.0244 |
| 1 | Antiseptic [EPC] | 33 | 0.0076 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 178 | 0.0010 |
| 3 | alpha-1 Adrenergic Agonist [EPC] | 3 | 0.0007 |
| 4 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 5 | 0.0004 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 8 | 0.0004 |
| 6 | Glycopeptide Antibacterial [EPC] | 20 | 0.0003 |
| 7 | Quinolone Antimicrobial [EPC] | 3 | 0.0003 |
| 8 | Complement Inhibitor [EPC] | 13 | 0.0002 |
| 9 | Anticholinergic [EPC] | 3 | 0.0002 |